DEK and breast carcinoma: In breast cancer cell lines, DEK overexpression promotes cell growth and mobility by inducing β-catenin nuclear translocation and enhances tumor growth and metastasis by activating Wnt/β-catenin autocrine and paracrine signaling loops [38, 39].